250
Participants
Start Date
June 17, 2025
Primary Completion Date
March 23, 2026
Study Completion Date
April 6, 2026
CX11
CX11 tablets administered orally once daily (QD) with meals
Placebo
Matching placebo tablets administered orally once daily (QD) with meals
Angels Clinical Research Institute, Miami
Oceanic Research Group, LLC, North Miami Beach
Velocity Clinical Research - Valparaiso (Buynak Clinical Research) - PPDS, Valparaiso
Mankato Clinic - East Main Street - Javara - PPDS, Mankato
Epic Clinical Research - Alliance Clinical - Lewisville, Lewisville
Velocity Clinical Research - Dallas - PPDS, Dallas
AES - DRS - Synexus Clinical Research US, Inc. - San Antonio, San Antonio
Flourish Research - San Antonio - PPDS, San Antonio
310 Clinical Research - Alliance Clinical - Los Angeles, Inglewood
Acclaim Clinical Research - Alliance Clinical - San Diego, San Diego
AES - DRS - Synexus Clinical Research US, Inc. - Phoenix Central, Phoenix
Angels Clinical Research Institute - Miami, Doral
AES - DRS - Optimal Research Florida - Melbourne, Melbourne
Palm Springs Community Health Center, Miami Lakes
Privia Medical Group Georgia, LLC - Savannah - Javara - PPDS, Savannah
Privia Medical Group Georgia, LLC - Thomasville - Javara - PPDS, Thomasville
Velocity Clinical Research - Cincinnati (Springdale) - Ohio - PPDS, Cincinnati
Lead Sponsor
Corxel Pharmaceuticals
INDUSTRY